Related Experiment Video
Updated: Apr 27, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
23.7K
Viral hepatitis: new data on hepatitis C infection
Erzsébet Szabó1, Gábor Lotz, Csilla Páska
12nd Department of Pathology, Semmelweis University, Budapest, H-1091, Hungary.
Pathology Oncology Research : POR
|December 23, 2003
Summary
Viral hepatitis (VH) affects millions globally, with hepatitis C virus (HCV) causing significant chronic liver disease and rising mortality. This review focuses on HCV
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Viral hepatitis (VH) is a significant global health issue with an estimated 3-5% prevalence.
- Hepatitis B virus (HBV) infects 400 million, and hepatitis C virus (HCV) infects 170 million people worldwide.
- Mortality from VH is projected to increase due to cirrhosis, a leading cause of liver transplantation.
Purpose of the Study:
- To review current knowledge on viral hepatitis, focusing on hepatitis C virus (HCV).
- To discuss HCV genotypes, viral-cell interactions, pathogenesis, and extrahepatic manifestations.
- To explore the role of HCV in hepatocarcinogenesis.
Main Methods:
- Literature review of recent advancements in viral hepatitis research.
- Focus on hepatitis C virus (HCV) due to its public health significance.
- Discussion of viral genotypes, pathogenesis, and clinical implications.
Main Results:
- Hepatitis C virus (HCV) is the leading cause of chronic liver disease globally.
- HCV infection is associated with increased mortality and cirrhosis.
- Ongoing research addresses viral characteristics and disease mechanisms.
Conclusions:
- Viral hepatitis, particularly HCV, remains a critical public health concern.
- Further research is needed to understand HCV pathogenesis and extrahepatic manifestations.
- Effective management and prevention strategies are essential to combat VH.
Related Concept Videos
Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
Cytomegalovirus Disease
96
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
96
Hepatitis
78
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
78
Viral Hepatitis I: Introduction
21
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
21
Cirrhosis I: Introduction
25
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
25
Cirrhosis II: Pathophysiology
33
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
33

